Systematic evaluation of plasma and urine metabolites to predict adverse kidney-related outcomes in chronic kidney disease: The GCKD study
Wolfram Gronwald(University of Regensburg), Harald Binder(Zimmer Biomet (Netherlands)), Ulla T. Schultheiß(Pediatrics and Genetics), Elke Schäeffner, Inga Steinbrenner(University of Freiburg), Charlotte Behning(University Hospital Bonn), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Anna Köttgen(University of Freiburg), Peggy Sekula(University of Freiburg), Peter J. Oefner
Cited by 0
Related Papers
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
|New England Journal of Medicine|2006|2.1k
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
|Kidney International|2007|1.5k
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
|American Journal of Transplantation|2009|1.5k